Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [986]

Editor's Choice for August 2016

Prof Gordon McVie - Editor in Chief, ecancer

Editor's Choice for August 2016 ( Prof Gordon McVie - Editor in Chief, ecancer )

Survivor perspectives of ALK lung cancer

Matthew Hiznay - Cleveland, Ohio, USA

Survivor perspectives of ALK lung cancer ( Matthew Hiznay - Cleveland, Ohio, USA )

Lung cancer immunotherapy

Dr Luis Raez - Memorial Cancer Institute, Hollywood, Florida, USA

Lung cancer immunotherapy ( Dr Luis Raez - Memorial Cancer Institute, Hollywood, Florida, USA )

'Other' targets in lung cancer

Dr Edward Garon - David Geffen School of Medicine at the University of California, Los Angeles, USA

'Other' targets in lung cancer ( Dr Edward Garon - David Geffen School of Medicine at the University of California, Los Angeles, USA )

Editor's Choice for July 2016

Prof Gordon McVie - Editor in Chief, ecancer

Editor's Choice for July 2016 ( Prof Gordon McVie - Editor in Chief, ecancer )

The steady progress of targeted therapies

Dr Anton Berns - Netherlands Cancer Institute, Amsterdam, Netherlands

The steady progress of targeted therapies ( Dr Anton Berns - Netherlands Cancer Institute, Amsterdam, Netherlands )

Prof Michael Seckl: Why attend Future Horizons in Lung Cancer?

Prof Michael Seckl - Imperial College London, London

Prof Michael Seckl: Why attend Future Horizons in Lung Cancer? ( Prof Michael Seckl - Imperial College London, London )

Polycomb repressors and epigenetic therapy

Dr Maarten van Lohuizen - Netherlands Cancer Institute, Netherlands, UK

Polycomb repressors and epigenetic therapy ( Dr Maarten van Lohuizen - Netherlands Cancer Institute, Netherlands, UK )

The changing process of drug discovery and design

Dr Ian Waddell - Cancer Research UK Manchester Institute, Manchester, UK

The changing process of drug discovery and design ( Dr Ian Waddell - Cancer Research UK Manchester Institute, Manchester, UK )

Mouse models of lung cancer

Dr Anton Berns - Netherlands Cancer Institute, Amsterdam, Netherlands

Mouse models of lung cancer ( Dr Anton Berns - Netherlands Cancer Institute, Amsterdam, Netherlands )

'Rewiring' tumour susceptibility

Dr Michael Yaffe - MIT, Cambridge, USA

'Rewiring' tumour susceptibility ( Dr Michael Yaffe - MIT, Cambridge, USA )

New targets in personalised therapy for patients with lung cancer

Prof Bruce Johnson - Dana-Farber Cancer Institute, Bethesda, USA

New targets in personalised therapy for patients with lung cancer ( Prof Bruce Johnson - Dana-Farber Cancer Institute, Bethesda, USA )

More from ecancer